Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.

Nicolas G Glynos, Anne Baker, Jacob S Aday, Daniel Kruger, Kevin F Boehnke, Stephanie Lake, Philippe Lucas

Abstract read

In one paragraph

Article in British journal of pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolas G GlynosAnesthesiology Department, University of MichiganMedical School, Ann Arbor, MI, USA.ORCID https://orcid.org/0000-0002-6952-131X

Anne BakerAnesthesiology Department, University of MichiganMedical School, Ann Arbor, MI, USA.

Jacob S AdayAnesthesiology Department, University of MichiganMedical School, Ann Arbor, MI, USA.

Daniel KrugerJacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

Kevin F BoehnkeAnesthesiology Department, University of MichiganMedical School, Ann Arbor, MI, USA.

Stephanie LakeUCLA Center for Cannabis and Cannabinoids, Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.

Philippe LucasMichigan Psychedelic Center, University of Michigan, Ann Arbor, MI, USA.ORCID https://orcid.org/0000-0003-1948-3842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychedelic substances have shown preliminary efficacy for several neuropsychiatric disorders and are currently being investigated for chronic pain conditions. However, few studies have investigated outcomes of naturalistic psychedelic use among individuals with chronic pain, and none have assessed psychedelic-related changes in substance use patterns in this population. In a cross-sectional survey of adults who reported using psychedelics to self-treat a chronic pain condition (

Indexed as

chronic painpsilocybinpsychedelicssubstance usesurvey

Identifiers

PMID39944237

DOI10.1177/20494637251319497

PMCPMC11811946

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.